Actics Hybrid insoles integrate seamlessly into users’ everyday lives, allowing freedom of choice in footwear. They empower patients and physicians to make more accurate, real-time treatment decisions, preventing complications before they happen.
Actics
Digitizing the future of foot therapy
Actics connects continuous sensing with personalized intervention, creating a new model of remote lower-limb care. Starting with diabetic foot.
Learn about our company
One platform. Starting where the need is the greatest
Other Conditions
Tens of millions suffer from neural disorders (such as Parkinson’s), obesity and age-related conditions that affect mobility and balance
Orthopedic Disorders
100M+ suffer from foot deformities, plantar fasciitis, arthritis, foot pain or injuries
Diabetic Foot
Over 80M are at high risk of Diabetic Foot Ulceration (DFU), Charcot and deformities, potentially facing amputations and death
Sports & Comfort
More and more people seek to upgrade sport performance and daily comfort
Clinical and economic burden of diabetic foot ulcers
In recent years, diabetic foot disease has grown to reach pandemic proportions.
147M
The number of patients affected by DFU (life-time occurrence)
50%
Risk of DFU recurrence within 2 yrs. 50%+ risk of mortality within 5 yrs. if amputated
$40-55K
Cost expenditure of DFU occurrence. Amputations can cost up to $100K
$60B
Annual US Diabetes related amputations expenditure
Advantages
Save lives, time, costs, and resources
Actics optimizes the efficiency and cost-effectiveness of care of foot disorders associated with diabetes, orthopedic and neural conditions. Between 15-25% of all diabetic patients are expected to develop Diabetic Foot Ulcer (DFU) at least once.
Solutions
Technology
that adapts to you
Protected by granted and pending patents
Actics combines continuous plantar pressure, temperature and gait sensing with personalized mechanical offloading and adherence monitoring. The platform is designed to help clinicians understand what is happening outside the clinic, intervene remotely, and measure the response over time. A continuous loop of care.
Optimized Foot Care from Diagnosis to Treatment
- Actics insoles predict the risk of DFU weeks before ulcers form
- Cloud-based monitoring & diagnosis improves real-time results
- Dynamic treatment powered by AI enhances offloading plans
- In-depth gait analysis will empower patients to maintain and improve mobility
Actics Hybrid+
Features and benefits
Real Time Alerts
Alerts patients to temperature and pressure overloads via the RPM platform, mobile app or the smart watch
Continuous Monitoring
Sends real-time temperature and pressure alerts to providers through remote software enabled by the cloud
Gait Analysis
Monitors a variety of additional gait and physiological parameters out-of-lab
Diagnostics and Remote Care
Informs clinicians about effective offloading treatments for plantar foot ulcers and preventing their recurrence
Dynamic Adjustments
Built-in mechanism for quick and unlimited personal (offloading) customizations
Wireless Connectivity & Charging
Mobile App and Bluetooth connectivity for patients. RPM Dashboard to caregiver
Commercial
Actics One
A prefabricated adjustable insole that enables clinicians to perform rapid, localized mechanical adjustments without waiting for a custom orthotic manufacturing cycle.
- Enables effective manual interventions by podiatrists and orthotists within minutes
- Comes with up to 52 custom adjustment points allowing maximum fit to almost any foot and any need
- Offers an off-the-shelf, instantly available, budget-friendly, and comfortable alternative to existing orthotics
Our Team
ABOUT RON
Ron Machanian is the Founder and CEO of Actics Medical and the inventor of its adjustable insole technology. He brings more than 15 years of technology and product leadership experience, including CTO and CPO roles, with a focus on digital health and connected care. He holds a B.Sc. in Information Systems Engineering and an MBA.
Ron Machanian
Founder & CEO
Link to Actics Linkedin page
ABOUT Yirmi
In addition to establishing and managing the HiTEC technology incubator, Yirmi is a long-time entrepreneur and has previously served as a director for various technology companies. He has a B.A. in Economics and an MBA.
Yirmi Egert
Chairman, Business Development
Link to Actics Linkedin page
ABOUT Gavriel
Gavriel is an experienced industrial manager who specializes in leading high-scale technical and operational development processes. He has a B.Sc. in Electrical Engineering and an MBA.
Gavriel Katz
Co-founder & VP of Engineering
ABOUT Ofer
Dr. Elishoov is a senior orthopedic surgeon specializing in diabetic foot care. He served as the Head of Foot and Ankle Services at Hadassah Medical Center in Jerusalem.
Ofer Elishoov, M.D.
Medical Director
ABOUT LEW
Awards Winning Researcher, Teacher and Investigator and renowned foot and ankle surgeon. A former president of the AOFAS and served on the AAOS communications cabinet. Director of Orthopaedic Innovation at Mercy, MD, a Clinical Prof. of Orthopaedics at NYU and Johns Hopkins. He is also consultant to Athletes & Professional Sports Teams
Prof. Lew Schon, M.D.
Advisory board, Orthopedics
Link to Actics Linkedin page
ABOUT David
Prof. Armstrong is a revered podiatrist and healthcare policy advisor whose groundbreaking research has transformed the care of diabetic foot ulcers. Widely recognized as a leading expert in podiatry and wound care, he serves on numerous committees that shape US healthcare delivery and reimbursement decisions, resulting in improved patient outcomes and reduced costs.
David G. Armstrong, DPM, PhD
Advisory board, Podiatry & Diabetic Foot
Link to Actics Linkedin page
ABOUT AVIVIT
Dr. Avivit Cahn, an esteemed endocrinologist at and Head of the Israeli Diabetic Foot and Wound Healing Society, enriches our advisory board with her expertise in big data, digital health, and personalized medicine. A graduate of Hebrew University with a fellowship at Hadassah Hebrew University Hospital, she has led significant clinical trials and authored over 80 publications, significantly advancing diabetic care.
Prof. Avivit Cahn, M.D.
Advisory board, Diabetes
ABOUT David
Dr. Pedowitz is a highly respected orthopedic surgeon and Chief of the Division of Foot and Ankle Surgery at Rothman Orthopaedics, where he leads one of the nation’s premier programs. He is also a Professor of Orthopaedic Surgery at Thomas Jefferson Sidney Kimmel Medical College. Dr. Pedowitz’s expertise is sought by top sports teams, including the Philadelphia Eagles and Phillies. Known for his pioneering work in total ankle replacements, he has made significant contributions to orthopedic research and global education.
David I. Pedowitz, M.D.
Advisory board, Orthopedics
Link to Actics Linkedin page
ABOUT meir
A world-class orthopedic surgeon specializing in biomechanics of the Foot and Ankle. Former president of the Israeli Foot and Ankle Society and former head of the Orthopedic Surgery Department at Meir General Hospital, Israel. Well-known researcher that authored more than 200 publications.
Prof. Meir Nyska, M.D.
Advisory board, Orthopedics